Profile data is unavailable for this security.
About the company
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
- Revenue in USD (TTM)32.32bn
- Net income in USD4.20bn
- Incorporated2014
- Employees95.00k
- LocationMedtronic PLC20 On Hatch, Hatch Street LowerDUBLIN 2IrelandIRL
- Phone+353 14381700
- Websitehttps://www.medtronic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Align Technology, Inc. | 3.86bn | 445.05m | 23.61bn | 21.61k | 53.96 | 6.49 | 40.20 | 6.11 | 5.81 | 5.81 | 50.43 | 48.36 | 0.642 | 3.64 | 4.38 | 178,725.60 | 7.40 | 16.34 | 11.07 | 24.14 | 70.08 | 71.72 | 11.52 | 23.16 | 1.04 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Zimmer Biomet Holdings Inc | 7.39bn | 1.02bn | 24.90bn | 18.00k | 24.79 | 2.00 | 12.59 | 3.37 | 4.89 | 4.89 | 35.26 | 60.70 | 0.3475 | 0.9195 | 5.24 | 410,794.40 | 4.82 | 2.21 | 5.49 | 2.52 | 71.82 | 71.25 | 13.86 | 7.28 | 0.7784 | 7.32 | 0.316 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Resmed Inc | 4.50bn | 890.39m | 27.03bn | 10.14k | 30.45 | 6.03 | 25.23 | 6.00 | 6.04 | 6.04 | 30.53 | 30.47 | 0.6633 | 2.10 | 6.17 | 444,189.10 | 13.11 | 13.59 | 14.74 | 15.89 | 55.11 | 56.98 | 19.77 | 19.22 | 1.89 | 19.64 | 0.2149 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| West Pharmaceutical Services Inc. | 2.95bn | 593.40m | 28.24bn | 10.60k | 48.93 | 9.84 | 39.60 | 9.57 | 7.88 | 7.88 | 39.19 | 39.20 | 0.7923 | 4.29 | 5.79 | 278,283.00 | 15.46 | 15.61 | 18.41 | 18.65 | 38.28 | 38.06 | 19.52 | 18.47 | 2.24 | -- | 0.067 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| GE HealthCare Technologies Inc | 19.55bn | 1.39bn | 39.57bn | 51.00k | 28.57 | 5.54 | 19.35 | 2.02 | 3.04 | 3.03 | 42.77 | 15.67 | 0.6518 | 5.65 | 4.44 | 383,372.60 | 5.39 | -- | 7.45 | -- | 40.52 | -- | 8.28 | -- | 0.8295 | 5.43 | 0.5636 | -- | 6.60 | -- | -26.82 | -- | -- | -- |
| Edwards Lifesciences Corp | 6.00bn | 1.40bn | 53.34bn | 19.80k | 38.50 | 8.01 | 34.54 | 8.88 | 2.30 | 2.30 | 9.85 | 11.06 | 0.6802 | 1.35 | 8.47 | 303,272.70 | 15.85 | 16.63 | 18.21 | 19.12 | 77.02 | 76.71 | 23.30 | 24.84 | 2.40 | -- | 0.0816 | 0.00 | 11.56 | 10.03 | -7.85 | 13.70 | 1.96 | -- |
| DexCom Inc | 3.62bn | 541.50m | 54.60bn | 9.60k | 107.54 | 25.69 | 75.05 | 15.07 | 1.28 | 1.28 | 8.55 | 5.37 | 0.6215 | 3.04 | 4.29 | 377,322.90 | 9.29 | 8.30 | 13.11 | 10.50 | 63.65 | 65.90 | 14.95 | 14.14 | 2.48 | -- | 0.5465 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
| Becton Dickinson and Co | 19.49bn | 1.27bn | 67.55bn | 73.00k | 53.36 | 2.67 | 19.05 | 3.47 | 4.38 | 4.23 | 67.25 | 87.68 | 0.3699 | 3.31 | 8.57 | 267,013.70 | 2.47 | 2.37 | 2.89 | 2.70 | 41.37 | 45.78 | 6.68 | 6.95 | 0.6435 | 6.45 | 0.3887 | 81.23 | 2.66 | 3.92 | -4.85 | 12.97 | -0.4737 | 3.94 |
| Medtronic PLC | 32.32bn | 4.20bn | 106.73bn | 95.00k | 25.48 | 2.06 | 15.46 | 3.30 | 3.15 | 3.15 | 24.27 | 38.95 | 0.3495 | 2.00 | 5.45 | 340,210.50 | 4.58 | 4.78 | 5.28 | 5.37 | 65.73 | 67.68 | 13.10 | 14.28 | 1.71 | 30.78 | 0.3263 | 72.49 | -1.45 | 0.8366 | -25.42 | -6.95 | 6.44 | 8.13 |
| Boston Scientific Corporation | 14.24bn | 1.57bn | 107.17bn | 48.00k | 68.07 | 5.54 | 38.75 | 7.53 | 1.07 | 1.07 | 9.73 | 13.16 | 0.4213 | 1.99 | 6.78 | 296,666.70 | 4.71 | 2.50 | 5.43 | 2.91 | 69.65 | 68.84 | 11.18 | 6.47 | 0.8170 | 5.16 | 0.3179 | 0.00 | 12.29 | 7.71 | 144.55 | -0.4276 | 7.82 | -- |
| Stryker Corp | 20.50bn | 3.17bn | 128.16bn | 52.00k | 40.84 | 6.89 | 30.57 | 6.25 | 8.25 | 8.25 | 53.42 | 48.92 | 0.5338 | 1.67 | 5.59 | 394,192.30 | 8.24 | 6.60 | 10.12 | 7.84 | 63.90 | 63.99 | 15.44 | 13.13 | 0.9689 | -- | 0.4114 | 43.70 | 11.11 | 8.55 | 34.22 | 9.68 | 0.1047 | 10.16 |
| Intuitive Surgical, Inc. | 7.32bn | 1.99bn | 132.92bn | 13.68k | 67.67 | 9.53 | 53.68 | 18.16 | 5.54 | 5.54 | 20.41 | 39.36 | 0.5068 | 2.19 | 7.13 | 535,134.60 | 13.88 | 12.42 | 15.39 | 13.83 | 66.43 | 67.60 | 27.38 | 26.31 | 4.61 | -- | 0.00 | 0.00 | 14.49 | 13.85 | 35.98 | 9.77 | 41.53 | -- |
Data as of Apr 25 2024. Currency figures normalised to Medtronic PLC's reporting currency: US Dollar USD
30.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 120.70m | 9.09% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 71.77m | 5.41% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 60.92m | 4.59% |
| Massachusetts Financial Services Co.as of 31 Dec 2023 | 28.89m | 2.18% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 28.84m | 2.17% |
| Geode Capital Management LLCas of 31 Dec 2023 | 26.73m | 2.01% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 24.01m | 1.81% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2023 | 17.81m | 1.34% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 16.20m | 1.22% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 14.93m | 1.12% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
